VAERS Bibliography for May 2004 - Vaccine Adverse Event ...

46. Krueger, M.; Fluegge, K.; Krause, M. F.; Berner, R. Fatal Haemophilus Influenzaetype b
Sepsis in a 10-Month-Old Infant Despite Complete Vaccination and Adequate Hib
Antibodies. Eur.J.Pediatr. April 15, 2004. [Epub ahead of print].
47. Kulkarni, V.; Nadgir, D.; Tapiawala, S.; Malabari, A.; Kalgikar, A.; Kela, R.; Nadkar, M.;
Kamath, S.; Shah, A. Biphasic Demyelination of the Nervous System Following Anti-Rabies
Vaccination. Neurol.India. 52 (1): 106-108; March, 2004.
48. Langue, J.; Matisse, N.; Pacoret, P.; Undreiner, F.; Boisnard, F.; Soubeyrand, B.
Persistence of Antibodies at 5-6 Years of Age for Children Who Had Received a Primary
Series Vaccination With a Pentavalent Whole-Cell Pertussis Vaccine and a First Booster
With a Pentavalent Acellular Pertussis Vaccine: Immunogenicity and Tolerance of Second
Booster With a Tetravalent Acellular Vaccine at 5-6 Years of Age. Vaccine. 22 (11-12):
1406-1414; March 29, 2004.
49. Letonturier, D. [Influenza Can Hide Other Infections]. Soins.Gerontol. (46): 42-45; March,
2004.
50. Mallet, E.; Matisse, N.; Mathieu, N.; Langue, J.; Boisnard, F.; Soubeyrand, B. Antibody
Persistence Against Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus
Influenzae Type b (Hib) in 5-6-Year-Old Children After Primary Vaccination and First
Booster With a Pentavalent Combined Acellular Pertussis Vaccine: Immunogenicity and
Tolerance of a Tetravalent Combined Acellular Pertussis Vaccine Given As a Second
Booster. Vaccine. 22 (11-12): 1415-1422; March 29, 2004.
51. March, J. B. DNA Vaccination - Research Tool or a Practical Reality?
Expert.Rev.Vaccines. 3 (2): 113-117; April, 2004.
52. McLaughlin, M. A. Thoughts on Rabies Vaccination Enforcement. J.Am.Vet.Med.Assoc.
224 (6): 834-835; March 15, 2004.
53. Micco, E.; Gurmankin, A. D.; Armstrong, K. Differential Willingness to Undergo Smallpox
Vaccination Among African-American and White Individuals. J.Gen.Intern.Med. 19 (5 Pt 1):
451-455; May, 2004.
54. Morgan, O. W.; Meltzer, M.; Muir, D.; Hogan, H.; Seng, C.; Hill, J.; Beckford, J. Specialist
Vaccination Advice and Pockets of Resistance to MMR Vaccination: Lessons From an
Outbreak of Measles. Commun.Dis.Public Health. 6 (4): 330-333; December, 2003.
55. Mullooly, J. P.; Maher, J. E.; Drew, L.; Schuler, R.; Hu, W. Evaluation of the Impact of an
HMO's Varicella Vaccination Program on Incidence of Varicella. Vaccine. 22 (11-12): 1480-
1485; March 29, 2004.
56. Nolan, P. The Rhode Island Meningitis Vaccine Experience--Mass Vaccination
Campaigns, Politics and Health Policy. Med.Health R.I. 87 (3): 65-67; March, 2004.
57. Nookala, S.; Srinivasan, S.; Kaliraj, P.; Narayanan, R. B.; Nutman, T. B. Impairment of
Tetanus-Specific Cellular and Humoral Responses Following Tetanus Vaccination in
Human Lymphatic Filariasis. Infect.Immun. 72 (5): 2598-2604; May, 2004.
58. Parlato, A.; Marinelli, A.; Alfieri, R.; Albano, L.; Liguori, G. [The Tetanus in Italy and in the
Campania Region: Retrospective Analysis. The Importance of Vaccinations]. Ig Sanita
Pubbl. 59 (6): 383-392; November, 2003.
59. Parve, J. Remove Vaccination Barriers for Children 12 to 24 Months. Nurse Pract. 29
(4): 35-38; April, 2004.
4/5